Ardent Health (ARDT) Cost of Revenue (2023 - 2026)

Ardent Health has reported Cost of Revenue for 4 years, with the latest figure at $165.2 million in Q1 2026.

• For the quarter ending Q1 2026, Cost of Revenue rose 26.29% year-over-year to $165.2 million; the trailing twelve-month figure through Mar 2026 stood at $805.1 million (down 22.74% YoY), and the FY2025 full-year result was $1.1 billion, up 4.82% from the prior year.
• Cost of Revenue for Q1 2026 stood at $165.2 million, down from $277.5 million in the prior quarter.
• The five-year high for Cost of Revenue was $678.3 million in Q4 2024, with the low at -$292.0 million in Q4 2023.
• Average Cost of Revenue over 4 years is $170.5 million, with a median of $147.2 million recorded in 2025.
• Year-over-year, Cost of Revenue surged 332.3% in 2024 and slumped 59.08% in 2025.
• Tracing ARDT's Cost of Revenue over 4 years: stood at -$292.0 million in 2023, then jumped by 332.3% to $678.3 million in 2024, then slumped by 59.08% to $277.5 million in 2025, then sank by 40.49% to $165.2 million in 2026.
• The last three Cost of Revenue figures came in at $165.2 million (Q1 2026), $277.5 million (Q4 2025), and $198.7 million (Q3 2025), per Business Quant data.

Peer Comparison